Cambi ASA Q2 2025 slides: record revenue amid strategic expansion and industry challenges

Cambi ASA reported a significant Q2 2025 financial recovery, achieving record revenue of NOK 342 million, an 11.8% year-over-year increase and a 52% jump from Q1, which contributed to its stock rebounding. While EBITDA declined 8.5% year-over-year, it saw a substantial 436% quarter-over-quarter improvement to NOK 75 million. Strategically, Cambi acquired a 51% stake in CNP CYCLES GmbH, expanding its technology offerings, and is addressing industry challenges like PFAS contamination with its THP technology, despite a year-over-year decline in its order backlog to NOK 938 million. The company's performance and authorized dividend signal renewed investor confidence, positioning it to capitalize on global demand for sustainable wastewater treatment solutions, albeit with ongoing gross margin pressures.

Analysis

Cambi ASA presented a significant financial recovery in its Q2 2025 results, rebounding sharply from a disappointing first quarter. The company achieved record quarterly revenue of NOK 342 million, an 11.8% year-over-year increase, which drove a 52% improvement from the prior quarter and helped its stock price recover to NOK 21.6. While revenue reached an all-time high, EBITDA declined 8.5% year-over-year to NOK 75 million, though this marked a substantial 436% sequential improvement from Q1's NOK 14 million. A key point of concern is the order backlog, which decreased significantly to NOK 938 million from NOK 1,484 million a year earlier, signaling potential future revenue headwinds despite a 61.9% increase in quarterly order intake. Strategically, Cambi is expanding its technology portfolio through the acquisition of a 51% stake in CNP CYCLES GmbH and is positioning itself to address regulatory challenges like PFAS contamination with its flexible THP technology. However, the company faces external pressures including a new 10% US-UK tariff, which it aims to mitigate via domestic manufacturing, and acknowledges intense competition in its target growth market of Germany. Management's confidence is underscored by strong operating cash flow and the approval of an additional dividend of up to NOK 0.70 per share.

Key Decisions for Investors

• Investors should weigh the strong operational turnaround, evidenced by record revenue and a dramatic quarter-over-quarter EBITDA recovery, against the significant year-over-year decline in the order backlog to NOK 938 million, which remains a primary risk to future growth.
• Monitor the company's ability to convert its strategic initiatives into tangible results, specifically its success in the competitive German market and the integration of the newly acquired CNP CYCLES technology.
• Consider the dividend authorization of up to NOK 0.70 per share as a strong signal of management's confidence in future cash flow, which may appeal to income-oriented investors.
• Factor in the emerging macroeconomic risks, such as the 10% US-UK tariff, and watch for company announcements regarding mitigation strategies like the establishment of US manufacturing facilities.